Saturday, August 13, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home News

New dual-plasmid editing system for DNA-based information rewriting in vivo

by Medical Finance
in News
Researchers create a DNA-based fluorescent nanoantenna to monitor the motions of proteins
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

DNA-based information is a new interdisciplinary field linking information technology and biotechnology. The field hopes to meet the enormous need for long-term data storage by using DNA as an information storage medium. Despite DNA’s promise of strong stability, high storage density and low maintenance cost, however, researchers face problems accurately rewriting digital information encoded in DNA sequences.

Generally, DNA data storage technology has two modes, i.e., the “in vitro hard disk mode” and the “in vivo CD mode.” The primary advantage of the in vivo mode is its low-cost, reliable replication of chromosomal DNA by cell replication. Due to this characteristic, it can be used for rapid and low-cost data copy dissemination. Since encoded DNA sequences for some information contain a large number of repeats and the appearance of homopolymers, however, such information can only be “written” and “read,” but cannot be accurately “rewritten.”

To solve the rewriting problem, Prof. Liu Kai from the Department of Chemistry, Tsinghua University, Prof. Li Jingjing from the Changchun Institute of Applied Chemistry (CIAC) of the Chinese Academy of Sciences, and Prof. Chen Dong from Zhejiang University led a research team that recently developed a dual-plasmid editing system for accurately processing digital information in a microbial vector. Their findings were published in Science Advances.

The researchers established a dual-plasmid system in vivo using a rationally designed coding algorithm and an information editing tool. This dual-plasmid system is suitable for storing, reading and rewriting various types of information, including text, codebooks and images. It fully explores the coding capability of DNA sequences without requiring any addressing indices or backup sequences. It is also compatible with various kinds of coding algorithms, thus enabling high coding efficiency. For example, the coding efficiency of the current system reaches 4.0 bits per nucleotide.

To achieve high efficiency as well as reliability in rewriting complex information stored in exogenous DNA sequences in vivo, a variety of CRISPR-associated proteins (Cas) and recombinase were used. The tools were guided by their corresponding CRISPR RNA (crRNA) to cleave a target locus in a DNA sequence so that the specific information could be addressed and rewritten. Because of the high specificity between complementary pairs of nucleic acid molecules, the information-encoded DNA sequences were accurately reconstructed by recombinase to encode new information. Due to optimizing the crRNA sequence, the information rewriting tool became highly adaptable to complex information, thus resulting in rewriting reliability of up to 94%, which is comparable to existing gene-editing systems.

The dual-plasmid system can serve as a universal platform for DNA-based information rewriting in vivo, thus offering a new strategy for information processing and target-specific rewriting of large and complicated data on a molecular level.

We believe this strategy can also be applied in a living host with a larger genome, such as yeast, which would further pave the way for practical applications regarding big data storage.”


Prof. Liu Kai, Department of Chemistry, Tsinghua University

Source:

Chinese Academy of Sciences Headquarters

Journal reference:

Liu, Y., et al. (2022) In vivo processing of digital information molecularly with targeted specificity and robust reliability. Science Advances. doi.org/10.1126/sciadv.abo7415.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Low profile microplates optimise space utilisation

Low profile microplates optimise space utilisation

by Medical Finance
August 13, 2022
0

Porvair Sciences low profile microplates offer the highly efficient use of stacking space that is essential to achieving efficient automation...

Study: Significance of the RBD mutations in the SARS-CoV-2 Omicron: from spike opening to antibody escape and cell attachment. Image Credit: Fit Ztudio/Shutterstock

Omicron RBD mutations increase ACE2 binding and reduce antibody sensitivity

by Medical Finance
August 13, 2022
0

In a study conducted at the Florida International University, USA, scientists have investigated the impact of spike receptor-binding domain (RBD)...

ANU researchers identify why Th17 cells go rogue and promote the onset of multiple sclerosis

ANU researchers identify why Th17 cells go rogue and promote the onset of multiple sclerosis

by Medical Finance
August 13, 2022
0

Researchers from The Australian National University (ANU) have identified why certain cells in the body, known as Th17 cells, go...

Study: Structural Basis for Nirmatrelvir in Vitro Efficacy against the Omicron Variant of SARS-CoV-2. Image Credit: Cryptographer / Shutterstock.com

Paxlovid provides a glimpse into the future against SARS-CoV-2

by Medical Finance
August 13, 2022
0

A recent study posted to the bioRxiv* preprint server reveals that an antiviral drug, nirmatrelvir, is potent and effective against...

New cryo-EM method may be able to shortcut a big step in modern vaccine development

New cryo-EM method may be able to shortcut a big step in modern vaccine development

by Medical Finance
August 13, 2022
0

Scientists at Scripps Research have devised a method that may be able to shortcut one of the big steps in...

New mathematical model can calculate the risk of resistance evolution for drug pairs

Discovery illuminates a blueprint to develop new antibiotics for killing bacteria

by Medical Finance
August 13, 2022
0

The Centers for Disease Control and Prevention estimates that more than 2.8 million Americans experience antibiotic-resistant infections each year; more...

Next Post
Scientists unravel how blood cells mount the first line of defense against viruses

NIH researchers develop three-dimensional structure of twinkle protein

Study: SARS-CoV-2 spreads through cell-to-cell transmission. Image Credit: MIA Studio/Shutterstock

SARS-CoV-2 shown to spread through cell-to-cell transmission

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Relation of incident Type 1 diabetes to recent COVID-19 infection: cohort study using e-health record linkage in Scotland. Image Credit: Gecko Studio/Shutterstock
    Study investigates whether SARS-CoV-2 infection is associated with increased risk of incident type 1 diabetes
  • Alzheimers amyloid plaque Juan Gaertner 9638f1223d534b518a192c8478871d65 620x480
    Novel fusion protein drug for Alzheimer’s disease circumvents the neurotoxic inflammatory side effects
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply